SEC Comment Letter for Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838) — Mar 30, 2020
Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)
Date: March 30, 2020 · CIK: 0001106838 · Accession: 0000000000-20-002755
AI Filing Summary & Sentiment
File numbers found in text: 333-237354
Letter
March 30, 2020 Michael D. Pruitt Chief Executive Officer Chanticleer Holdings, Inc. 7621 Little Avenue, Suite 414 Charlotte, NC 28226 Re:Chanticleer Holdings, Inc. Registration Statement on Form S-3 Filed March 24, 2020 File No. 333-237354 Dear Mr. Pruitt: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Katherine Bagley at (202) 551-2545 with any questions. Sincerely, Division of Corporation Finance Office of Trade & Services cc: Ruba Qashu
Show Raw Text
March 30, 2020
Michael D. Pruitt
Chief Executive Officer
Chanticleer Holdings, Inc.
7621 Little Avenue, Suite 414
Charlotte, NC 28226
Re:Chanticleer Holdings, Inc.
Registration Statement on Form S-3
Filed March 24, 2020
File No. 333-237354
Dear Mr. Pruitt:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Katherine Bagley at (202) 551-2545 with any questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services
cc: Ruba Qashu